Centre de recherches sur les macromolécules végétales
The CERMAV, a CNRS research unit (UPR 5301) celebrates its 55th anniversary in 2021. During more than half a century, five directors have succeeded each other and have been able to develop the axes of this research unit. The themes historically focused on cellulose and lignin, then on plant polysaccharides of economic importance (cellulose and starch) have diversified and now cover different areas of glycosciences, whether towards the synthesis or biosynthesis of biologically active oligosaccharides, the uses of biomass, nanocomposite materials or glycopolymers
Partner
News from Cermav
Thirty years of scientific collaboration between the CNRS and Taiwan
On September 18th, 2023, an international conference celebrated the thirtieth anniversary of the first framework agreement between the CNRS and the Taiwanese National Science &
Glyco@Alps Scientific Day 2023
We are pleased to invite you to the glycoscience day on Friday 13 October 2023 at the MACI (339 av centrale, 38400 Saint Martin d’Hères).
Ons Dakhlaoui thesis defense on September 07th, 2023
The thesis, entitled “Improving selective DNP (SelDNP) for biomolecular applications”, was funded by the Labex ARCANE and co-directed by Sabine Hediger (MEM – CEA) and
AIS Biotech wins the i-LAB 2023 competition
The AIS BIOTECH start-up, resulting from the work of Cermav, is laureate of the i-Lab 2023 Competition of BPI France.
Antoine DESIGAUX’s thesis defense on June 27th, 2023
Antoine DESIGAUX completed his thesis at Cermav under the co-supervision of Laurent HEUX (CNRS Research Director) and Sonia MOLINA – BOISSEAU (Université Grenoble Alpes Senior lecturer). It is entitled « Development as well as mechanical and structural characterization of an anisotropic elastomer reinforced by cellulose microfibrils. ».
Creation of the new start-up resulting from the work of Cermav, AIS Biotech
AIS Biotech relies on innovative, efficient, industrializable biotechnology with low environmental impact, to develop a new class of anti-infective biomedicines. Click on the title for more information.
